#USA #Berkeley Heights #pharmaceuticals #Frost & Sullivan #Axtria

Axtria Named Leader in Frost & Sullivan's Pharmaceutical Commercialization Industry Radar Report

Axtria Inc., a global leader in cloud software and data analytics tailored for the life sciences sector, has made headlines with its prominent positioning as the top performer in Frost & Sullivan's first-ever Pharmaceutical Commercialization Solutions and Services Industry Radar Report, released recently.

This commendation underscores Axtria's substantial advancements and leadership within the pharmaceutical commercialization sphere. Aarti Chitale from Frost & Sullivan pointed out, "Axtria's relentless focus on innovation and sustainable growth continues to set it apart as a leading commercial solutions and services provider. By leveraging advanced data science and cloud-based analytics platforms, Axtria empowers pharmaceutical companies to optimize their commercialization processes and improve patient outcomes on a global scale."

Frost & Sullivan's assessment was framed around two vital indices: the Growth Index (GI), evaluating a company's performance and growth strategy execution, and the Innovation Index (II), which gauges the development of customer-centric solutions addressing significant market shifts.

Jassi Chadha, President and CEO of Axtria, shared insights about the company's mission, stating, "At Axtria, our goal is to become the most admired data analytics company, assisting the global life sciences industry to achieve unparalleled efficiency and effectiveness. We are honored to be recognized as a leader in this inaugural report, as it represents our commitment to innovation. We leverage cutting-edge technologies, including AI, to transform operations, facilitate smarter decision-making, and improve patient outcomes, ultimately shaping the future of healthcare."

Key Highlights from the Report

Innovation Excellence

Axtria has distinguished itself through its innovative utilization of data science and cloud-based analytics platforms. This empowers life sciences companies to improve the quality of patient care. Its comprehensive suite of platforms—including Axtria DataMAx, Axtria InsightsMAx, Axtria SalesIQ, Axtria CustomerIQ, and Axtria MarketingIQ—facilitates efficient data use, helping pharmaceutical entities streamline sales, marketing, and overall commercial operations.

Sustainable Growth Leadership

Operating in more than 70 countries with a workforce exceeding 3,800 professionals, Axtria showcases consistent annual double-digit growth. Recent expansions include:

• - New Global Innovation Centers: Axtria has broadened its headquarters in New Jersey and launched its 10th center in Hyderabad, India.
• - Expanding Workforce: Plans are in place to increase the employee count by over 1,000, particularly in data science, software development, and data engineering roles.
• - Global Footprint: These expansions signify Axtria's dedication to scaling operations and reinforcing global healthcare innovation.

Recognition and Strategic Initiatives

Axtria's emphasis on thought leadership and knowledge dissemination amplifies its brand recognition. In June 2024, the firm hosted over 350 senior executives from 65 leading pharmaceutical organizations at Axtria Ignite. The event focused on critical industry themes like patient engagement, the role of generative AI, and effective omnichannel strategies. This proactive approach positions Axtria at the forefront of transforming pharmaceutical commercialization through technology.

About Axtria's Offerings

Axtria prides itself on collaborating with 16 of the top 20 life sciences companies worldwide. Transitioning from its origins as a trusted consultancy to one of the leading providers of cloud-powered pharmaceutical management software, Axtria champions digital transformation within life sciences. Its expertise spans the entire lifecycle of pharmaceutical products—from brand launches to retirements.

Solutions like Axtria InsightsMAx™, Axtria SalesIQ™, Axtria CustomerIQ™, and Axtria MarketingIQ™ are designed to help stakeholders at all levels make informed decisions. Additionally, the Axtria DataMAx™ framework ensures uncompromising data management with top-tier security and integration capabilities.

Commitment to Data Science in Healthcare

Axtria is devoted to harnessing data science and software to boost patient outcomes by aligning the right therapies with appropriate patients in a timely manner. Recognized as a preeminent global provider of celebrated cloud software and data analytics for the life sciences industry, Axtria aims to assist pharmaceutical, medical device, and diagnostics companies in translating data to actionable insights. Furthermore, as a participant of the United Nations Global Compact, the company aligns its operations with fundamental principles concerning human rights, labor, the environment, and anti-corruption, actively supporting social goals. For additional information, visit www.axtria.com.